Background
==========

The cultivated sunflower (*Helianthus annuus* L.) is one of 67 species in the genus *Helianthus*. It is a dicotyledonous plant and a member of the *Compositae* (*Asteraceae*) family, having a typical composite flower \[[@B1]\]. The composition of the seed is markedly affected by the sunflower variety \[[@B2],[@B3]\]. Nevertheless, the composition ranges of sunflower dehulled seeds (on a percentage dry weight basis) is as follows \[[@B4]\]: protein ^20.4--40.0%^; peptides, amino acids and other non--protein nitrogen ^1--13%^; carbohydrates ^4--10%^; lipids ^47--65%^; fatty acids (palmitic acid ^5--7%^, atearic ^2--6%^; arachidic acid ^0.0--0.3%^, oleic acid ^15--37%^; linoleic acid ^51--73%^, and linolenic acid ^*\<*0*.*3%^); tocopherol ^0.07%^; carotenoids ^0.01--0.02%^; vitamin B1 ^0.002%^; chlorogenic acid (CGA) ^0.5--2.4%^; quinic acid (QA) ^0.12--0.25%^; caffeic acid (CA) ^0.05--0.29%^; total minerals ^3--4%^; potassium ^0.67--0.75%^; phosphorus ^0.60--0.94%^; sulphur ^0.26--0.32%^; magnesium ^0.35--0.41%^; calcium ^0.08--0.10%^; and sodium ^0.02%^.

Tocopherols are excellent natural antioxidants that protect oils against oxidative rancidity. The α form has the highest biological vitamin E activity, and the γ form has been reported to have the highest antioxidant activity \[[@B5]\]. The sterols found in sunflower oils include β-sitosterol, stigmasterol, campesterol, δ-5-avenasterol, and δ-7-stigmasterol \[[@B6],[@B7]\]. Plant sterols are only minimally absorbed by humans, and their ingestion appears to inhibit intestinal cholesterol and bile acid absorption \[[@B8]\]. Most trace metals in refined, bleached and deodorized sunflower seed oil are removed during processing. It is particularly important that copper and iron be removed because these metals greatly reduce the oxidative stability of the oil \[[@B9]\]. Other metals, such as lead and cadmium, are of particular concern due to their toxicity and their supposed link to coronary heart disease and hypertension \[[@B10]\].

In drug development, the genotoxicity assays represent a considerable effort, as most pharmaceutical organizations evaluate a new therapeutic agent based on *in vitro* and *in vivo* data genotoxic \[[@B11]\]. In this context, tests to evaluate the genotoxic activity of the plants used by the population as well as their isolated compounds are necessary and important for establishing control measures in widespread use. Furthermore, it is necessary to clarify the mechanisms and conditions that mediate the proposed biological effect before plants are considered as therapeutic agents \[[@B12]\]. As far as genotoxicity studies are concerned, the *in vivo* micronucleus (MN) assay in rodent bone marrow plays a crucial role in the test battery aimed at identifying hazardous mutagens \[[@B13]\]; this assay is especially suited to assessing genotoxic hazards because it allows consideration of multiple factors, such as *in vivo* metabolism, pharmacokinetics and DNA repair processes, even though these processes vary among species, among tissues and among genetic endpoints \[[@B14]-[@B17]\]. In addition, understanding the genotoxic effects induced by phytotherapeutics and foods employing the mammalian *in vivo* MN assay has been the goal of several researchers groups \[[@B18]-[@B20]\].

In order to contribute to the information on the genotoxic potential of herbal extracts and food, the present study evaluated the genotoxic effects of two sources of oil and tincture of *H. annuus* L. (sunflower) seeds using *in vivo* micronucleus assays in mouse bone marrow. The effect of the maximum permissible concentration of *H. annuus* L. (oils and tincture) on the doxorubicin (DXR)--induced genotoxic effects in mice bone marrow was also studied (i.e., antigenotoxicity assay).

Methods
=======

Phytotherapeutics
-----------------

Tincture and oil of sunflower seeds were purchased commercially and stored according to the manufacturer\'s recommendations \[tincture of *H. annuus* L. seeds (THALS) -- Yod Comércio de Produtos Naturais Ltda., cat. \# 544606, Campinas, SP, Brazil; pharmaceutical oil of *H. annuus* L. seeds (POHALS) -- Farmácia de Manipulação Alfenense Ltda., Alfenas, MG, Brazil; food oil of *H. annuus* L. seeds (FOHALS) -- Agricultural Cargill S.A., Mairinque, SP, Brazil\]. Aliquots (1.5 L) of this tincture were submitted to solvent removal proceedings by rotary evaporation (40 rpm) (Rotavapor Model R-215) coupled in bath heating systems ^50--60°C^ (Bath Heating model B-491), vacuum pump ^500\ mmHg^ (Vacuum Pump V-700 with Automatic Vacuum Controller V-855), recirculator (Recirculator Chiller F-100) and evaporation bottle (Büchi Labortechnik AG, Switzerland). The final product was transferred to a reaction bottle 1 L (SCHOTT^®^ DURAN^®^) and kept at -20°C for 24 hours in order to evaluate the freezing of the final product and the efficacy of the solvent evaporation process \[[@B21]\]. Then, aliquots (40 mL) of this final product was transferred into glass vials penicillin type (50 mL) and lyophilized (Lyophilizer model Alpha 1--2 LDPlus, Martin Christ Gefriertrocknungsanlagen GmbH^©^, Germany) and their dry mass were measured (Electronic Analytical Balance AUW-220D, Shimadzu Corp., Kyoto, Japan). The lyophilized final product was prepared in aqueous solvent (150 mM NaCl in water type 1) at concentrations of 2×, sterilized by filtration (Millipore Corporation, hydrophilic Durapore^®^ PVDF, 0.22 μm, ∅ 47 mm, cat. \# GVWP 047 00), and stored in sterile polypropylene tubes (50 mL) at -70°C until moment of use.

System -- test *in vivo*
------------------------

Healthy, heterogeneous, young adult male and female *Swiss albinus* (Unib: SW) mice (between 7 and 12 weeks -- pubescent period), with a body weight between 30 g and 40 g (i.e., the variation weight between the animals, for each sex, should not exceed the ± 20% of medium mass) were provided by CEMIB (*Centro Multidisciplinar para Investigação Biológica na Área da Ciência em Animais de Laboratório* -- UNICAMP; <http://www.cemib.unicamp.br/>), and erythrocytes from the bone marrow of these mice were used in the micronucleus assay \[[@B14],[@B17],[@B22]\]. The animals were kept in groups of the same sex, in polypropylene boxes, in an air--conditioned environment to 22°C ± 3°C, with relative air humidity of 50% ± 20%, and with 12--hour day--night cycles (i.e., 12 h light and 12 h dark). These were fed with Purina^®^ Labina commercial rations (Nestlé Purina Pet Care Company) and water *ad libitum*, and acclimated to laboratory conditions for 7 days (a trial period) before the execution of the experiment. At the end of the trial period, each animal was weighed and, according to the weight, received 2 mL/100 g body weight of the indicated liquid (negative control, positive control, chemotherapeutic and phytotherapeutic). After the experimental treatment, the animals were euthanized by CO~2~ asphyxiation in adapted acrylic chambers \[[@B14]\]. This research was approved by Committee of Ethics in Research Involving Animals of UNIFENAS (CEPEAU Protocol No. 04A/2008).

Experimental groups
-------------------

Groups of animals (consisting of 3 males and 3 females each) were treated using a single dosing regimen administered by gavage (phytotherapeutic and negative control) or intraperitoneally (chemotherapeutic and positive control) and two euthanasia times (24 and 48 h), based on a regulatory recommendation regarding the *in vivo* micronucleus assay \[[@B14],[@B17]\]:

▪ Control groups: 150 mM NaCl (negative control), 50 mg.Kg^-1^ of N-Nitroso-N-ethylurea (positive control: NEU, Sigma N8509, CAS no. 759-73-9) and 5 mg.Kg^-1^ of doxorubicin hydrochloride \[[@B20]\] (chemotherapeutic: DXR, Eurofarma Laboratórios Ltda., CAS no. 23214-92-8).

▪ Genotoxicity test (phytotherapeutics): THALS (250--2,000 mg.Kg^-1^), POHALS (250--2,000 mg.Kg^-1^) and FOHALS (250--2,000 mg.Kg^-1^). The maximum tolerated dose (MTD) was defined as (*i*) the highest dose that can be administered without inducing lethality or excessive toxicity during the study causing moribund euthanasia, or (*ii*) a dose that produces some indication of toxicity of the bone marrow (e.g. a reduction in the proportion of immature erythrocytes among total erythrocytes in the bone marrow), or (*iii*) 2,000 mg.Kg^-1^\[[@B14],[@B17]\].

▪ Antigenotoxicity test 1 (phytotherapeutics + chemotherapeutic) \[[@B20]\]: THALS (2,000 mg.Kg^-1^) + DXR (5 mg.Kg^-1^), FOHALS (2,000 mg.Kg^-1^) + DXR (5 mg.Kg^-1^) and FOHALS (2,000 mg.Kg^-1^) + DXR (5 mg.Kg^-1^).

▪ Antigenotoxicity test 2 (phytotherapeutics + positive control): THALS (2,000 mg.Kg^-1^) + NEU (50 mg.Kg^-1^), POHALS (2,000 mg.Kg^-1^) + NEU (50 mg.Kg^-1^) and POHALS (2,000 mg.Kg^-1^) + NEU (50 mg.Kg^-1^).

Processing the bone marrow and cell analysis
--------------------------------------------

Shortly after euthanasia, the femora were surgically and aseptically removed, and the animals appropriately discarded. Each femur was sectioned at the proximal end and the contents of the spinal canal were washed with 1.5 mL of 150 mM NaCl solution and transferred to a 15 mL centrifuge tube \[[@B14],[@B17],[@B23]\]. This material was resuspended with a Pasteur pipette to ensure a random distribution of bone marrow cells. The suspension was then centrifuged at 1,000 rpm (*Centrífuga de Bancada Microprocessada*, Mod. NT 810, Nova Técnica Ind. e Com. de Equip. para Laboratório Ltda., Piracicaba, SP, Brazil) for 5 minutes. The supernatant was discarded and the resulting sediment was resuspended in 500 μL of 150 mM NaCI solution added 4% formaldehyde. The slides were prepared by smearing (2 slides per animal), dried at room temperature for 24 h and stained with Leishman\'s eosin methylene blue dye \[pure dye for 3 min, followed by diluted dye in water type 1 (1:6) for 15 min\] to differentiate polychromatic erythrocyte (PCE) from normochromatic erythrocyte (NCE).

Polychromatic erythrocytes (PCEs) were observed at a magnification of 1000× using optical microscopy (Nikon Eclipse E--200), counted (at least 2000 polychromatic erythrocytes anucleated per animal were scored for the incidence of micronucleated polychromatic erythrocytes) with the aid of a digital cell counter (Contador Diferencial CCS02, Kacil Indústria e Comércio Ltda., PE, Brasil Contador Diferencial CCS02, Kacil Indústria e Comércio Ltda., PE, Brazil) and photographed using an 8.1 Megapixel Digital Camera (DC FWL 150). The number of PCEs and NCEs, the number and frequency of micronucleated polychromatic erythrocytes (MNPCEs) were reported. In order to evaluate bone-marrow toxicity, the ratio of PCE to NCE was also observed \[[@B14],[@B17]\]. This PCE/NCE ratio is an indicator of the acceleration or inhibition of erythropoiesis and it has been reported to vary with scoring time. A continuous decline in the PCE/NCE ratio may be due to the inhibition of cell division, the killing of erythroblasts, the removal of damaged cells, or dilution of the existing cell pool with newly formed cells \[[@B20]\].

Statistical analysis
--------------------

The data obtained in the micronucleus assay were submitted to *one--way* analysis of variance (ANOVA), using a factorial scheme of 10 × 2 × 2 (treatment × sex × euthanasia time), and medium comparison with Tukey\'s test (α = 0.05) using SAS^®^ version 9.2 computer software.

Results and discussion
======================

*H. annuus* L. has been considered an important source of natural oil for centuries and has been used as a preventive medicine against diuresis, diarrhoea, and various inflammatory diseases \[[@B24]\], and has also been used for the relief of asthmatic symptoms \[[@B25]\], gastric protection \[[@B26],[@B27]\], its healing properties \[[@B28]\], anti-inflammatory action \[[@B29]\] and antimicrobial properties \[[@B26],[@B28]\]. However, studies aimed at understanding the genotoxic and mutagenic effects of *H. annuus* L. were subject of comparatively little research \[[@B19],[@B30]\], which drove us to evaluate the harmful genotoxic and antigenotoxic properties (i.e., clastogenicity and/or aneugenicity) of oil and tincture of *H. annuus* L. seeds using the MN assay *in vivo*.

The numbers and frequencies of MNPCEs and the PCE/NCE ratio in the bone marrow of mice were analyzed statistically for each one of the animal groups treated with only tincture (THALS) or oils (POHALS or FOHALS) of sunflower seeds -- genotoxic assays -- and for each one of the groups treated with phytotherapeutics and chemotherapeutic agent DXR (THALS + DXR, POHALS + DXR or FOHALS + DXR) -- antigenotoxic assays --, as well as control groups.

For animal groups treated with THALS, analysis of the MNPCEs showed no significant differences (*p* \< 0.05) between all the treatment doses (250--2,000 mg.Kg^-1^) and negative control (NaCl). These results suggest absence of genotoxicity of THALS, regardless of the dose of phytotherapic administration (250--2,000 mg.Kg^-1^), the treatment time (24 and 48 h) or the sex of the animal (male and female). Treatment of mice with 5 mg.Kg^-1^ DXR significantly induced MNPCE at 24 and 48 h post treatment and for both sexes, whose MNPCE frequencies were significantly above (*p* \< 0.05) those observed in the positive NEU control (50 mg.Kg^-1^). However, the reduction in MNPCE (*p* \< 0.05) was observed when THALS (2,000 mg.Kg^-1^) is administered in combination with the chemotherapy agent DXR (5 mg.Kg^-1^), suggesting antigenotoxic effects (anticlastogeny and/or antianeugeny). Therefore, THALS provides a partial protection against the genotoxic effects induced by DXR in the bone marrow of mice, regardless of the treatment time (24 and 48 h) or the sex of the animal, although the genotoxic effect observed in this treatment combination has is similar (i.e., numbers and frequencies of MNPCEs) to that observed in NEU-treated animals. The analysis obtained from the PCE/NCE ratio showed no significant differences (*p* \< 0.05) between all doses of THALS (250--2,000 mg.Kg^-1^), THALS (2,000 mg.Kg^-1^) + DXR (5 mg.Kg^-1^) and negative controls. These results suggest that there is not systemic toxicity of THALS and/or DXR under the MN assay conditions, regardless of the phytotherapeutic doses and times, but sex-dependent (Table [1](#T1){ref-type="table"}).

###### 

**The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female*Swiss albinus*mice after testing for 24 h and 48 h**

  **Treatment**                                                     **Number of PCEs analyzed**   **PCEMNs**   **PCE/(PCE + NCE)**   **NCE (*n*)**                                                                                     
  ----------------------------------------------------------------- ----------------------------- ------------ --------------------- --------------- ----------------- ----------------- ----------------- ----------------- --------- --------
  *150 mM NaCl*                                                                                                                                                                                                                        
  ♀~1~                                                              2095                          2097         7                     10              0.33              0.48              1.00              1.00              5         3
  ♀~2~                                                              2094                          2095         9                     10              0.43              0.48              1.00              1.00              6         5
  ♀~3~                                                              2087                          2089         11                    8               0.53              0.38              0.99              0.99              13        11
  Σ ♀                                                               Σ 6276                        Σ 6281       Σ 27                  Σ 28            0.43 ±0.10        0.45 ±0.05        1.00 ±0.00        1.00 ±0.00        Σ 24      Σ 19
  ♂~1~                                                              2095                          2088         9                     13              0.43              0.62              1.00              0.99              5         12
  ♂~2~                                                              2055                          2088         12                    11              0.58              0.53              0.98              0.99              45        12
  ♂~3~                                                              2058                          2084         7                     11              0.34              0.53              0.98              0.99              42        16
  Σ ♂                                                               Σ 6208                        Σ 6260       Σ 28                  Σ 35            0.45 ±0.12        0.56 ±0.06        0.99 ±0.01        0.99 ± 0.00       Σ 92      Σ 40
  Σ ♂ and ♀                                                         Σ 12484                       Σ 12541      Σ 55 ^A^              Σ 63 ^A^        0.44 ±0.08 ^A'^   0.50 ±0.06 ^A'^   0.99 ±0.01 ^A"^   1.00 ±0.00 ^A"^   Σ 116     Σ 59
  *N--Nitroso--N--ethylurea -- NEU (50 mg.Kg*^*-1*^*)*                                                                                                                                                                                 
  ♀~1~                                                              2148                          2075         38                    36              1.77              1.73              0.49              0.65              2252      1125
  ♀~2~                                                              1884                          2032         32                    34              1.70              1.67              0.54              0.81              1616      468
  ♀~3~                                                              2002                          1948         15                    31              0.75              1.59              0.61              0.93              1298      152
  Σ ♀                                                               Σ 6034                        Σ 6055       Σ 85                  Σ 101           1.41 ±0.57        1.67 ±0.07        0.54 ±0.06        0.80 ±0.14        Σ 5166    Σ 1745
  ♂~1~                                                              2025                          1999         64                    31              3.16              1.55              0.41              0.36              2875      3501
  ♂~2~                                                              2028                          1916         105                   40              5.18              2.09              0.51              0.55              1972      1584
  ♂~3~                                                              2004                          2069         25                    38              1.25              1.84              0.67              0.65              996       1131
  Σ ♂                                                               Σ 6057                        Σ 5984       Σ 194                 Σ 109           3.20 ±1.97        1.83 ±0.27        0.53 ±0.13        0.52 ±0.14        Σ 5843    Σ 6216
  Σ ♂ and ♀                                                         Σ 12091                       Σ 12039      Σ 279 ^B^             Σ 210 ^B^       2.30 ±1.66 ^B'^   1.75 ±0.18 ^B'^   0.54 ±0.06 ^B"^   0.66 ±0.16 ^B"^   Σ 11009   Σ 7961
  *Doxorubicin hydrochloride -- DXR (5 mg.Kg*^*-1*^*)*                                                                                                                                                                                 
  ♀~1~                                                              2091                          2017         49                    36              2.34              1.78              0.72              0.96              809       83
  ♀~2~                                                              2106                          2077         73                    63              3.47              3.03              0.98              0.99              44        23
  ♀~3~                                                              2056                          2092         57                    50              2.77              2.39              0.84              0.95              394       108
  Σ ♀                                                               Σ 6253                        Σ 6186       Σ 179                 Σ 149           2.86 ±0.57        2.40 ±0.62        0.85 ±0.13        0.97 ±0.02        Σ 1247    Σ 214
  ♂~1~                                                              2067                          2086         53                    61              2.56              2.92              0.98              0.95              33        114
  ♂~2~                                                              2063                          2042         56                    70              2.71              3.43              0.98              0.97              37        58
  ♂~3~                                                              2082                          2075         46                    50              2.21              2.41              0.99              0.99              18        25
  Σ ♂                                                               Σ 6212                        Σ 6203       Σ 155                 Σ 181           2.50 ±0.26        2.92 ±0.51        0.99 ±0.00        0.97 ±0.02        Σ 88      Σ 197
  Σ ♂ and ♀                                                         Σ 12465                       Σ 12389      Σ 334^C^              330^C^          2.68 ±0.42 ^C'^   2.66 ±0.43 ^C'^   0.92 ±0.07 ^A"^   0.97 ±0.01 ^A"^   Σ 1335    Σ 411
  *THALS -- Tincture of H. annuus L. seeds (250 mg.Kg*^*-1*^*)*                                                                                                                                                                        
  ♀~1~                                                              2097                          2192         8                     7               0.38              0.32              0.99              0.99              14        12
  ♀~2~                                                              2105                          2057         7                     12              0.33              0.58              0.99              0.99              31        28
  ♀~3~                                                              2181                          2092         12                    12              0.55              0.57              0.99              1.00              19        8
  Σ ♀ ^A\ A^                                                        Σ 6383                        Σ 6341       Σ 27                  Σ 31            0.42 ±0.11        0.49 ±0.15        0.99 ±0.00        0.99 ±0.01        Σ 64      Σ 48
  ♂~1~                                                              2041                          2070         7                     7               0.34              0.34              0.99              1.00              27        10
  ♂~2~                                                              2050                          2062         9                     6               0.44              0.29              0.99              0.99              17        19
  ♂~3~                                                              2055                          2065         10                    12              0.49              0.58              0.99              0.99              12        15
  Σ ♂ ^A\ A^                                                        Σ 6146                        Σ 6197       Σ 26                  Σ 25            0.42 ±0.07        0.40 ±0.16        0.99 ±0.00        0.99 ±0.00        Σ 56      Σ 44
  Σ ♂ and ♀                                                         Σ 12529                       Σ 12538      Σ 53 ^A^              Σ 56 ^A^        0.42 ±0.09 ^A'^   0.45 ±0.14 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 120     Σ 92
  *THALS -- Tincture of H. annuus L. seeds (500 mg.Kg*^*-1*^*)*                                                                                                                                                                        
  ♀~1~                                                              2086                          2146         12                    16              0.58              0.75              0.99              0.99              17        22
  ♀~2~                                                              2078                          2060         12                    13              0.58              0.63              0.99              0.99              25        11
  ♀~3~                                                              2072                          2046         13                    11              0.63              0.54              0.99              0.99              30        26
  Σ ♀ ^A\ A^                                                        Σ 6236                        Σ 6252       Σ 37                  Σ 40            0.59 ±0.03        0.64 ±0.10        0.99 ±0.00        0.99 ±0.00        Σ 72      Σ 59
  ♂~1~                                                              2071                          2075         17                    8               0.82              0.39              0.98              0.99              32        13
  ♂~2~                                                              2074                          2081         12                    11              0.58              0.53              0.99              0.99              29        20
  ♂~3~                                                              2072                          2067         11                    10              0.53              0.48              0.99              0.99              22        11
  Σ ♂ ^A\ A^                                                        Σ 6217                        Σ 6223       Σ 40                  Σ 29            0.64 ±0.16        0.47 ±0.07        0.99 ±0.00        0.99 ±0.00        Σ 83      Σ 44
  Σ ♂ and ♀                                                         Σ 12453                       Σ 12475      Σ 77 ^A^              Σ 69 ^A^        0.62 ±0.10 ^A'^   0.55 ±0.12 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 155     Σ 103
  *THALS -- Tincture of H. annuus L. seeds (1,000 mg.Kg*^*-1*^*)*                                                                                                                                                                      
  ♀~1~                                                              2083                          2165         13                    17              0.62              0.79              0.98              0.99              35        17
  ♀~2~                                                              2075                          2076         12                    14              0.58              0.67              0.99              0.99              24        25
  ♀~3~                                                              2070                          2061         13                    14              0.63              0.68              0.98              0.98              49        34
  Σ ♀ ^A\ A^                                                        Σ 6228                        Σ 6302       Σ 38                  Σ 45            0.61 ±0.03        0.71 ±0.06        0.98 ±0.01        0.99 ±0.00        Σ 108     Σ 76
  ♂~1~                                                              2079                          2084         18                    10              0.87              0.48              0.98              0.99              32        31
  ♂~2~                                                              2092                          2095         13                    11              0.62              0.53              0.99              0.99              30        21
  ♂~3~                                                              2073                          2077         11                    8               0.53              0.39              0.98              0.98              32        40
  Σ ♂ ^A\ A^                                                        Σ 6244                        Σ 6256       Σ 42                  Σ 29            0.67 ±0.17        0.46 ±0.07        0.99 ±0.00        0.99 ±0.00        Σ 94      Σ 92
  Σ ♂ and ♀                                                         Σ 12472                       Σ 12558      Σ 80 ^A^              Σ 74 ^A^        0.64 ±0.12 ^A'^   0.59 ±0.15 ^A'^   0.98 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 202     Σ 168
  *THALS -- Tincture of H. annuus L. seeds (1,500 mg.Kg*^*-1*^*)*                                                                                                                                                                      
  ♀~1~                                                              2057                          2171         13                    17              0.63              0.78              0.98              0.98              42        39
  ♀~2~                                                              2061                          2063         14                    18              0.68              0.87              0.99              0.98              31        36
  ♀~3~                                                              2026                          2090         10                    11              0.49              0.53              0.98              0.99              44        23
  Σ ♀ ^A\ A^                                                        Σ 6144                        Σ 6324       Σ 37                  Σ 46            0.60 ±0.10        0.73 ±0.18        0.98 ±0.00        0.98 ±0.00        Σ 117     Σ 98
  ♂~1~                                                              2075                          2048         14                    12              0.67              0.59              0.98              0.98              45        48
  ♂~2~                                                              2063                          2076         13                    8               0.63              0.39              0.97              0.99              58        24
  ♂~3~                                                              2068                          2079         17                    15              0.82              0.72              0.98              0.99              41        31
  Σ ♂ ^A\ A^                                                        Σ 6206                        Σ 6203       Σ 44                  Σ 35            0.71 ±0.10        0.56 ±0.17        0.98 ±0.00        0.98 ±0.01        Σ 144     Σ 103
  Σ ♂ and ♀                                                         Σ 12350                       Σ 12527      Σ 81 ^A^              Σ 81 ^A^        0.66 ±0.11 ^A'^   0.65 ±0.18 ^A'^   0.98 ±0.00 ^A"^   0.98 ±0.00 ^A"^   Σ 261     Σ 201
  *THALS -- Tincture of H. annuus L. seeds (2,000 mg.kg*^*-1*^*)*                                                                                                                                                                      
  ♀~1~                                                              2055                          2061         15                    14              0.73              0.68              0.97              0.98              59        39
  ♀~2~                                                              2052                          2060         17                    19              0.83              0.92              0.97              0.98              62        40
  ♀~3~                                                              2079                          2061         15                    15              0.72              0.73              0.98              0.98              35        39
  Σ ♀ ^A\ A^                                                        Σ 6186                        Σ 6182       Σ 47                  Σ 48            0.76 ±0.06        0.78 ±0.13        0.98 ±0.01        0.98 ±0.00        Σ 156     Σ 118
  ♂~1~                                                              2145                          2071         22                    10              1.03              0.48              0.97              0.99              58        29
  ♂~2~                                                              2064                          2028         8                     12              0.39              0.59              0.98              0.97              40        72
  ♂~3~                                                              2047                          2071         18                    15              0.88              0.72              0.97              0.99              56        29
  Σ ♂ ^A\ A^                                                        Σ 6256                        Σ 6170       Σ 48                  Σ 37            0.76 ±0.33        0.60 ±0.12        0.98 ±0.00        0.98 ±0.01        Σ 154     Σ 130
  Σ ♂ and ♀                                                         Σ 12442                       Σ 12352      Σ 95 ^A^              Σ 85 ^A^        0.76 ±0.21 ^A'^   0.69 ±0.15 ^A'^   0.98 ±0.01 ^A"^   0.98 ±0.01 ^A"^   Σ 310     Σ 248
  *THALS (2 g.kg*^*-1*^*) + NEU (50 mg.Kg*^*-1*^*)*                                                                                                                                                                                    
  ♀~1~                                                              2074                          2048         27                    32              1.30              1.56              0.99              0.85              26        352
  ♀~2~                                                              2070                          2076         30                    27              1.45              1.30              0.99              0.99              30        24
  ♀~3~                                                              2079                          2083         32                    33              1.54              1.58              0.99              0.99              21        17
  Σ ♀ ^A\ A^                                                        Σ 6223                        Σ 6207       Σ 89                  Σ 92            1.43 ±0.12        1.48 ±0.16        0.99 ±0.00        0.94 ±0.08        Σ 77      Σ 393
  ♂~1~                                                              2077                          2076         35                    37              1.69              1.78              0.99              0.99              23        24
  ♂~2~                                                              2075                          2078         36                    35              1.73              1.68              0.99              0.99              25        22
  ♂~3~                                                              2077                          2074         32                    37              1.54              1.78              0.99              0.99              23        26
  Σ ♂ ^A\ A^                                                        Σ 6229                        Σ 6228       Σ 103                 Σ 109           1.65 ±0.10        1.75 ±0.06        0.99 ±0.00        0.99 ±0.00        Σ 71      Σ 72
  Σ ♂ and ♀                                                         Σ 12452                       Σ 12435      Σ 192 ^B^             Σ 201 ^B^       1.54 ±0.16 ^B'^   1.62 ±0.18 ^B'^   0.99 ±0.00 ^A"^   0.97 ±0.06 ^A"^   Σ 148     Σ 465
  *THALS (2 g.kg*^*-1*^*) + DXR (5 mg.Kg*^*-1*^*)*                                                                                                                                                                                     
  ♀~1~                                                              2074                          2075         36                    38              1.74              1.83              0.99              0.99              26        25
  ♀~2~                                                              2075                          2079         36                    29              1.73              1.39              0.99              0.99              25        21
  ♀~3~                                                              2074                          2082         34                    36              1.64              1.73              0.99              0.99              26        18
  Σ ♀ ^A\ A^                                                        Σ 6223                        Σ 6236       Σ 106                 Σ 103           1.70 ±0.06        1.65 ±0.23        0.99 ±0.00        0.99 ±0.00        Σ 77      Σ 64
  ♂~1~                                                              2080                          2089         34                    28              1.63              1.34              0.99              0.99              20        11
  ♂~2~                                                              2081                          2077         30                    34              1.44              1.64              0.99              0.99              19        23
  ♂~3~                                                              2090                          2082         33                    34              1.58              1.63              1.00              0.99              10        18
  Σ ♂ ^A\ A^                                                        Σ 6251                        Σ 6248       Σ 97                  Σ 96            1.55 ±0.10        1.54 ±0.17        0.99 ±0.00        0.99 ±0.00        Σ 49      Σ 52
  Σ ♂ and ♀                                                         Σ 12474                       Σ 12484      Σ 203 ^B^             Σ 199 ^B^       1.63 ±0.11 ^B'^   1.59 ±0.19 ^B'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 126     Σ 116

Means with the same letter are not significantly different (*p* \< 0.05).

Shown are data from the controls (NaCl, NEU and DXR), an evaluation of the genotoxicity of THALS, and an evaluation of the antigenotoxicity of THALS (THALS + NEU and THALS + DXR).

For animal groups treated with POHALS (Table [2](#T2){ref-type="table"}) or FOHALS (Table [3](#T3){ref-type="table"}), analysis of the MNPCEs showed no significant differences (*p* \< 0.05) between all the treatment doses (250--2,000 mg.Kg^-1^) and negative control (NaCl). These results suggest absence of genotoxicity for both sources of sunflower oil (pharmaceutical and food), regardless of the dose of oil administration (250--2,000 mg.Kg^-1^) or treatment time (24 and 48 h), but it was sex-dependent. Treatment of mice with DXR (5 mg.Kg^-1^) + POHALS (2,000 mg.Kg^-1^) or DXR (5 mg.Kg^-1^) + FOHALS (2,000 mg.Kg^-1^) not contribute to the MNPCEs reduction at 24 and 48 h post treatment and for both sexes, suggesting that both sources of sunflower oil not decrease the DXR-induced genotoxic effects and therefore they do not have antigenotoxic effects (anticlastogeny and/or antianeugeny). The analysis obtained from the PCE/NCE ratio showed no significant differences (*p* \< 0.05) between all doses of POHALS (250--2,000 mg.Kg^-1^) and negative controls, time-dependent and sex-independent. For FOHALS, the PCE/NCE ratio showed significant differences (*p* \< 0.05) only in the highest dose (2,000 mg.Kg^-1^) tested, time-independent and sex-dependent. These results suggest that the systemic toxicity of sunflower oil can be dependent on its source and its highest dose used. In addition, treatments with DXR (5 mg.Kg^-1^) + POHALS (2,000 mg.Kg^-1^) or DXR (5 mg.Kg^-1^) + FOHALS (2,000 mg.Kg^-1^) significantly decrease the PCE/NCE ratio in mouse bone marrow. These results suggests that the association sunflower oil and chemotherapeutic agent DXR can potentize the systemic toxicity, regardless of the sex (only POHALS) and time (only FOHALS).

###### 

**The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female*Swiss albinus*mice after testing for 24 h and 48 h**

  **Treatment**                                                                 **Number of PCEs analyzed**   **PCEMNs**   **PCE/(PCE + NCE)**   **NCE (*n*)**                                                                                     
  ----------------------------------------------------------------------------- ----------------------------- ------------ --------------------- --------------- ----------------- ----------------- ----------------- ----------------- --------- --------
  *150 mM NaCl*                                                                                                                                                                                                                                    
  ♀~1~                                                                          2095                          2097         7                     10              0.33              0.48              1.00              1.00              5         3
  ♀~2~                                                                          2094                          2095         9                     10              0.43              0.48              1.00              1.00              6         5
  ♀~3~                                                                          2087                          2089         11                    8               0.53              0.38              0.99              0.99              13        11
  Σ ♀                                                                           Σ 6276                        Σ 6281       Σ 27                  Σ 28            0.43 ±0.10        0.45 ±0.05        1.00 ±0.00        1.00 ±0.00        Σ 24      Σ 19
  ♂~1~                                                                          2095                          2088         9                     13              0.43              0.62              1.00              0.99              5         12
  ♂~2~                                                                          2055                          2088         12                    11              0.58              0.53              0.98              0.99              45        12
  ♂~3~                                                                          2058                          2084         7                     11              0.34              0.53              0.98              0.99              42        16
  Σ ♂                                                                           Σ 6208                        Σ 6260       Σ 28                  Σ 35            0.45 ±0.12        0.56 ±0.06        0.99 ±0.01        0.99 ± 0.00       Σ 92      Σ 40
  Σ ♂ and ♀                                                                     Σ 12484                       Σ 12541      Σ 55 ^A^              Σ 63 ^A^        0.44 ±0.08 ^A'^   0.50 ±0.06 ^A'^   0.99 ±0.01 ^A"^   1.00 ±0.00 ^A"^   Σ 116     Σ 59
  *N--Nitroso--N--ethylurea -- NEU (50 mg.Kg*^*--1*^*)*                                                                                                                                                                                            
  ♀~1~                                                                          2148                          2075         38                    36              1.77              1.73              0.49              0.65              2252      1125
  ♀~2~                                                                          1884                          2032         32                    34              1.70              1.67              0.54              0.81              1616      468
  ♀~3~                                                                          2002                          1948         15                    31              0.75              1.59              0.61              0.93              1298      152
  Σ ♀                                                                           Σ 6034                        Σ 6055       Σ 85                  Σ 101           1.41 ±0.57        1.67 ±0.07        0.54 ±0.06        0.80 ±0.14        Σ 5166    Σ 1745
  ♂~1~                                                                          2025                          1999         64                    31              3.16              1.55              0.41              0.36              2875      3501
  ♂~2~                                                                          2028                          1916         105                   40              5.18              2.09              0.51              0.55              1972      1584
  ♂~3~                                                                          2004                          2069         25                    38              1.25              1.84              0.67              0.65              996       1131
  Σ ♂                                                                           Σ 6057                        Σ 5984       Σ 194                 Σ 109           3.20 ±1.97        1.83 ±0.27        0.53 ±0.13        0.52 ±0.14        Σ 5843    Σ 6216
  Σ ♂ and ♀                                                                     Σ 12091                       Σ 12039      Σ 279 ^B^             Σ 210 ^B^       2.30 ±1.66 ^B'^   1.75 ±0.18 ^B'^   0.54 ±0.06 ^C"^   0.66 ±0.16 ^C"^   Σ 11009   Σ 7961
  *Doxorubicin hydrochloride -- DXR (5 mg.Kg*^*--1*^*)*                                                                                                                                                                                            
  ♀~1~                                                                          2091                          2017         49                    36              2.34              1.78              0.72              0.96              809       83
  ♀~2~                                                                          2106                          2077         73                    63              3.47              3.03              0.98              0.99              44        23
  ♀~3~                                                                          2056                          2092         57                    50              2.77              2.39              0.84              0.95              394       108
  Σ ♀                                                                           Σ 6253                        Σ 6186       Σ 179                 Σ 149           2.86 ±0.57        2.40 ±0.62        0.85 ±0.13        0.97 ±0.02        Σ 1247    Σ 214
  ♂~1~                                                                          2067                          2086         53                    61              2.56              2.92              0.98              0.95              33        114
  ♂~2~                                                                          2063                          2042         56                    70              2.71              3.43              0.98              0.97              37        58
  ♂~3~                                                                          2082                          2075         46                    50              2.21              2.41              0.99              0.99              18        25
  Σ ♂                                                                           Σ 6212                        Σ 6203       Σ 155                 Σ 181           2.50 ±0.26        2.92 ±0.51        0.99 ±0.00        0.97 ±0.02        Σ 88      Σ 197
  Σ ♂ and ♀                                                                     Σ 12465                       Σ 12389      Σ 334 ^C^             330 ^C^         2.68 ±0.42 ^C'^   2.66 ±0.43 ^C'^   0.92 ±0.07 ^A"^   0.97 ±0.01 ^A"^   Σ 1335    Σ 411
  *POHALS -- Pharmaceutical oil of H. annuus L. seeds (250 mg.Kg*^*--1*^*)*                                                                                                                                                                        
  ♀~1~                                                                          2081                          2092         9                     7               0.43              0.33              0.99              1.00              14        10
  ♀~2~                                                                          2086                          2087         5                     8               0.24              0.38              0.99              1.00              13        9
  ♀~3~                                                                          2090                          2084         8                     8               0.38              0.38              1.00              0.99              7         12
  Σ ♀ ^A\ A^                                                                    Σ 6257                        Σ 6263       Σ 22                  Σ 23            0.35 ±0.10        0.37 ±0.03        0.99 ±0.00        1.00 ±0.00        Σ 34      Σ 31
  ♂~1~                                                                          2082                          2083         10                    16              0.48              0.77              0.99              0.99              18        11
  ♂~2~                                                                          2085                          2099         7                     9               0.34              0.43              0.99              1.00              15        9
  ♂~3~                                                                          2089                          2072         9                     15              0.43              0.72              0.99              0.99              11        21
  Σ ♂ ^B\ A^                                                                    Σ 6256                        Σ 6254       Σ 26                  Σ 40            0.42 ±0.07        0.64 ±0.18        0.99 ±0.00        0.99 ±0.00        Σ 44      Σ 41
  Σ ♂ and ♀                                                                     Σ 12513                       Σ 12517      Σ 48 ^A^              Σ 63 ^A^        0.38 ±0.09 ^A'^   0.50 ±0.19 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 78      Σ 72
  *POHALS -- Pharmaceutical oil of H. annuus L. seeds (500 mg.Kg*^*--1*^*)*                                                                                                                                                                        
  ♀~1~                                                                          2021                          2075         6                     6               0.30              0.29              1.00              0.99              9         13
  ♀~2~                                                                          2047                          2087         9                     11              0.44              0.53              0.99              1.00              11        8
  ♀~3~                                                                          2034                          2089         8                     7               0.39              0.34              0.99              0.99              14        11
  Σ ♀ ^A\ A^                                                                    Σ 6102                        Σ 6251       Σ 23                  Σ 24            0.38 ±0.07        0.38 ±0.13        0.99 ±0.00        0.99 ±0.00        Σ 34      Σ 32
  ♂~1~                                                                          2055                          2057         10                    11              0.49              0.53              0.99              0.99              28        18
  ♂~2~                                                                          2067                          2071         18                    15              0.87              0.72              0.99              0.99              11        16
  ♂~3~                                                                          2076                          2082         16                    19              0.77              0.91              1.00              0.99              7         12
  Σ ♂ ^B\ A^                                                                    Σ 6198                        Σ 6210       Σ 44                  Σ 45            0.71 ±0.20        0.72 ±0.19        0.99 ±0.01        0.99 ±0.00        Σ 46      Σ 46
  Σ ♂ and ♀                                                                     Σ 12300                       Σ 12461      Σ 67 ^A^              Σ 69 ^A^        0.54 ±0.24 ^A'^   0.55 ±0.24 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 80      Σ 78
  *POHALS -- Pharmaceutical oil of H. annuus L. seeds (1,000 mg.Kg*^*--1*^*)*                                                                                                                                                                      
  ♀~1~                                                                          2088                          2091         15                    11              0.72              0.53              0.99              1.00              12        7
  ♀~2~                                                                          2084                          2086         9                     16              0.43              0.77              0.99              0.99              14        14
  ♀~3~                                                                          2090                          2080         11                    9               0.53              0.43              1.00              0.99              10        11
  Σ ♀ ^A\ A^                                                                    Σ 6262                        Σ 6257       Σ 35                  Σ 36            0.56 ±0.15        0.58 ±0.17        0.99 ±0.00        0.99 ±0.00        Σ 36      Σ 32
  ♂~1~                                                                          2071                          2077         14                    23              0.68              1.11              0.99              0.99              18        18
  ♂~2~                                                                          2087                          2093         21                    15              1.01              0.72              0.99              0.99              13        11
  ♂~3~                                                                          2084                          2079         17                    15              0.82              0.72              0.99              0.99              16        17
  Σ ♂ ^B\ A^                                                                    Σ 6242                        Σ 6249       Σ 52                  Σ 53            0.83 ±0.17        0.85 ±0.22        0.99 ±0.00        0.99 ±0.00        Σ 47      Σ 46
  Σ ♂ and ♀                                                                     Σ 12504                       Σ 12506      Σ 87 ^A^              Σ 89 ^A^        0.70 ±0.20 ^A'^   0.71 ±0.23 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 83      Σ 78
  *POHALS -- Pharmaceutical oil of H. annuus L. seeds (1,500 mg.Kg*^*--1*^*)*                                                                                                                                                                      
  ♀~1~                                                                          2091                          2088         15                    11              0.72              0.53              1.00              0.99              10        12
  ♀~2~                                                                          2091                          2102         10                    15              0.48              0.71              1.00              1.00              9         8
  ♀~3~                                                                          2084                          2076         12                    12              0.58              0.58              0.99              0.99              19        14
  Σ ♀ ^A\ A^                                                                    Σ 6266                        Σ 6266       Σ 37                  Σ 38            0.59 ±0.12        0.61 ±0.10        0.99 ±0.00        0.99 ±0.00        Σ 38      Σ 34
  ♂~1~                                                                          2079                          2084         21                    20              1.01              0.96              0.99              0.99              21        16
  ♂~2~                                                                          2083                          2067         18                    17              0.86              0.82              0.99              0.99              19        21
  ♂~3~                                                                          2091                          2085         17                    21              0.81              1.01              0.99              0.99              18        15
  Σ ♂ ^B\ A^                                                                    Σ 6253                        Σ 6236       Σ 56                  Σ 58            0.90 ±0.10        0.93 ±0.10        0.99 ±0.00        0.99 ±0.00        Σ 58      Σ 52
  Σ ♂ and ♀                                                                     Σ 12519                       Σ 12502      Σ 93 ^A^              Σ 96 ^A^        0.74 ±0.19 ^A'^   0.77 ±0.20 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 96      Σ 86
  *POHALS -- Pharmaceutical oil of H. annuus L. seeds (2,000 mg.kg*^*--1*^*)*                                                                                                                                                                      
  ♀~1~                                                                          2084                          2091         18                    17              0.86              0.81              0.99              1.00              17        9
  ♀~2~                                                                          2089                          2087         16                    18              0.77              0.86              0.99              0.99              15        13
  ♀~3~                                                                          2091                          2085         9                     13              0.43              0.62              0.99              0.99              11        15
  Σ ♀ ^A\ A^                                                                    Σ 6264                        Σ 6263       Σ 43                  Σ 48            0.69 ±0.23        0.77 ±0.13        0.99 ±0.00        0.99 ±0.00        Σ 43      Σ 37
  ♂~1~                                                                          2071                          2074         24                    25              1.16              1.21              0.98              0.98              36        32
  ♂~2~                                                                          2085                          2086         18                    19              0.86              0.91              0.98              0.99              33        28
  ♂~3~                                                                          2048                          2078         15                    18              0.73              0.87              0.99              0.99              27        30
  Σ ♂ ^B\ A^                                                                    Σ 6204                        Σ 6238       Σ 57                  Σ 62            0.92 ±0.22        0.99 ±0.18        0.98 ±0.00        0.99 ±0.00        Σ 96      Σ 90
  Σ ♂ and ♀                                                                     Σ 12468                       Σ 12501      Σ 100 ^A^             Σ 110 ^A^       0.80 ±0.24 ^A'^   0.88 ±0.19 ^A'^   0.99 ±0.00 ^A"^   0.99 ±0.00 ^A"^   Σ 139     Σ 127
  *POHALS (2 g.kg*^*--1*^*) + NEU (50 mg.Kg*^*--1*^*)*                                                                                                                                                                                             
  ♀~1~                                                                          2040                          2054         67                    51              3.28              2.48              0.73              0.68              760       946
  ♀~2~                                                                          2042                          2068         61                    61              2.99              2.95              0.73              0.65              758       1132
  ♀~3~                                                                          2039                          2007         54                    64              2.65              3.19              0.70              0.69              861       893
  Σ ♀ ^A\ A^                                                                    Σ 6121                        Σ 6129       Σ 182                 Σ 176           2.97 ±0.32        2.87 ±0.36        0.72 ±0.01        0.67 ±0.02        Σ 2379    Σ 2971
  ♂~1~                                                                          2038                          2014         46                    52              2.26              2.58              0.64              0.69              1162      886
  ♂~2~                                                                          2011                          2072         54                    59              2.69              2.85              0.67              0.80              989       528
  ♂~3~                                                                          2008                          2053         49                    49              2.44              2.39              0.69              0.76              892       647
  Σ ♂ ^B\ A^                                                                    Σ 6057                        Σ 6139       Σ 149                 Σ 160           2.46 ±0.21        2.61 ±0.23        0.67 ±0.03        0.75 ±0.05        Σ 3043    Σ 2061
  Σ ♂ and ♀                                                                     Σ 12178                       Σ 12268      Σ 331 ^C^             Σ 336 ^C^       2.72 ±0.37 ^C'^   2.74 ±0.31 ^C'^   0.69 ±0.04 ^B"^   0.71 ±0.06 ^B"^   Σ 5422    Σ 5032
  *POHALS (2 g.kg*^*--1*^*) + DXR (5 mg.Kg*^*--1*^*)*                                                                                                                                                                                              
  ♀~1~                                                                          2034                          2166         76                    52              3.74              2.40              0.64              0.83              1166      434
  ♀~2~                                                                          2069                          2015         51                    49              2.46              2.43              0.69              0.69              931       885
  ♀~3~                                                                          2017                          2066         52                    59              2.58              2.86              0.70              0.69              883       934
  Σ ♀ ^A\ A^                                                                    Σ 6120                        Σ 6247       Σ 179                 Σ 160           2.93 ±0.70        2.56 ±0.25        0.67 ±0.03        0.74 ±0.08        Σ 2980    Σ 2253
  ♂~1~                                                                          2057                          2017         53                    55              2.58              2.73              0.66              0.78              1043      583
  ♂~2~                                                                          2056                          2037         73                    51              3.55              2.50              0.59              0.75              1444      663
  ♂~3~                                                                          2081                          2021         47                    49              2.26              2.42              0.74              0.78              719       579
  Σ ♂ ^B\ A^                                                                    Σ 6194                        Σ 6075       Σ 173                 Σ 155           2.80 ±0.67        2.55 ±0.16        0.66 ±0.08        0.77 ±0.01        Σ 3206    Σ 1825
  Σ ♂ and ♀                                                                     Σ 12314                       Σ 12322      Σ 352 ^C^             Σ 315 ^C^       2.86 ±0.62 ^C'^   2.56 ±0.19 ^C'^   0.67 ±0.05 ^B"^   0.75 ±0.05 ^B"^   Σ 6186    Σ 4078

Means with the same letter are not significantly different (*p* \< 0.05).

Shown are data from the controls (NaCl, NEU and DXR), an evaluation of the genotoxicity of POHALS, and an evaluation of the antigenotoxicity of POHALS (POHALS + NEU and POHALS + DXR).

###### 

**The incidence of MNPCEs and PCE/NCE ratio in bone marrow of male and female*Swiss albinus*mice after testing for 24 h and 48 h**

  **Treatment**                                                      **Number of PCEs analyzed**   **PCEMNs**   **PCE/(PCE + NCE)**   **NCE (*n*)**                                                                                       
  ------------------------------------------------------------------ ----------------------------- ------------ --------------------- --------------- ----------------- ----------------- ------------------ ------------------ --------- --------
  *150 mM NaCl*                                                                                                                                                                                                                           
  ♀~1~                                                               2095                          2097         7                     10              0.33              0.48              1.00               1.00               5         3
  ♀~2~                                                               2094                          2095         9                     10              0.43              0.48              1.00               1.00               6         5
  ♀~3~                                                               2087                          2089         11                    8               0.53              0.38              0.99               0.99               13        11
  Σ ♀                                                                Σ 6276                        Σ 6281       Σ 27                  Σ 28            0.43 ±0.10        0.45 ±0.05        1.00 ±0.00         1.00 ±0.00         Σ 24      Σ 19
  ♂~1~                                                               2095                          2088         9                     13              0.43              0.62              1.00               0.99               5         12
  ♂~2~                                                               2055                          2088         12                    11              0.58              0.53              0.98               0.99               45        12
  ♂~3~                                                               2058                          2084         7                     11              0.34              0.53              0.98               0.99               42        16
  Σ ♂                                                                Σ 6208                        Σ 6260       Σ 28                  Σ 35            0.45 ±0.12        0.56 ±0.06        0.99 ±0.01         0.99 ± 0.00        Σ 92      Σ 40
  Σ ♂ and ♀                                                          Σ 12484                       Σ 12541      Σ 55 ^A^              Σ 63 ^A^        0.44 ±0.08 ^A'^   0.50 ±0.06 ^A'^   0.99 ±0.01 ^A"^    1.00 ±0.00 ^A"^    Σ 116     Σ 59
  *N--Nitroso--N--ethylurea -- NEU (50 mg.Kg*^*-1*^*)*                                                                                                                                                                                    
  ♀~1~                                                               2148                          2075         38                    36              1.77              1.73              0.49               0.65               2252      1125
  ♀~2~                                                               1884                          2032         32                    34              1.70              1.67              0.54               0.81               1616      468
  ♀~3~                                                               2002                          1948         15                    31              0.75              1.59              0.61               0.93               1298      152
  Σ ♀                                                                Σ 6034                        Σ 6055       Σ 85                  Σ 101           1.41 ±0.57        1.67 ±0.07        0.54 ±0.06         0.80 ±0.14         Σ 5166    Σ 1745
  ♂~1~                                                               2025                          1999         64                    31              3.16              1.55              0.41               0.36               2875      3501
  ♂~2~                                                               2028                          1916         105                   40              5.18              2.09              0.51               0.55               1972      1584
  ♂~3~                                                               2004                          2069         25                    38              1.25              1.84              0.67               0.65               996       1131
  Σ ♂                                                                Σ 6057                        Σ 5984       Σ 194                 Σ 109           3.20 ±1.97        1.83 ±0.27        0.53 ±0.13         0.52 ±0.14         Σ 5843    Σ 6216
  Σ ♂ and ♀                                                          Σ 12091                       Σ 12039      Σ 279 ^B^             Σ 210 ^B^       2.30 ±1.66 ^B'^   1.75 ±0.18 ^B'^   0.54 ±0.06 ^D"^    0.66 ±0.16 ^D"^    Σ 11009   Σ 7961
  *Doxorubicin hydrochloride -- DXR (5 mg.Kg*^*-1*^*)*                                                                                                                                                                                    
  ♀~1~                                                               2091                          2017         49                    36              2.34              1.78              0.72               0.96               809       83
  ♀~2~                                                               2106                          2077         73                    63              3.47              3.03              0.98               0.99               44        23
  ♀~3~                                                               2056                          2092         57                    50              2.77              2.39              0.84               0.95               394       108
  Σ ♀                                                                Σ 6253                        Σ 6186       Σ 179                 Σ 149           2.86 ±0.57        2.40 ±0.62        0.85 ±0.13         0.97 ±0.02         Σ 1247    Σ 214
  ♂~1~                                                               2067                          2086         53                    61              2.56              2.92              0.98               0.95               33        114
  ♂~2~                                                               2063                          2042         56                    70              2.71              3.43              0.98               0.97               37        58
  ♂~3~                                                               2082                          2075         46                    50              2.21              2.41              0.99               0.99               18        25
  Σ ♂                                                                Σ 6212                        Σ 6203       Σ 155                 Σ 181           2.50 ±0.26        2.92 ±0.51        0.99 ±0.00         0.97 ±0.02         Σ 88      Σ 197
  Σ ♂ and ♀                                                          Σ 12465                       Σ 12389      Σ 334^C^              330^C^          2.68 ±0.42 ^C'^   2.66 ±0.43 ^C'^   0.92 ±0.07 ^AB"^   0.97 ±0.01 ^AB"^   Σ 1335    Σ 411
  *FOHALS -- Food oil of H. annuus L. seeds (250 mg.Kg*^*-1*^*)*                                                                                                                                                                          
  ♀~1~                                                               2137                          2019         11                    9               0.51              0.45              0.99               0.99               24        14
  ♀~2~                                                               2142                          2073         7                     14              0.33              0.68              1.00               1.00               8         5
  ♀~3~                                                               2146                          2016         9                     7               0.42              0.35              0.99               1.00               12        6
  Σ ♀ ^A\ A^                                                         Σ 6425                        Σ 6108       Σ 27                  Σ 30            0.42 ±0.09        0.49 ±0.17        0.99 ±0.00         1.00 ±0.00         Σ 44      Σ 25
  ♂~1~                                                               2061                          2079         6                     10              0.29              0.48              0.95               0.94               98        140
  ♂~2~                                                               2093                          2093         8                     7               0.38              0.33              0.99               0.99               31        20
  ♂~3~                                                               2050                          2041         8                     6               0.39              0.29              0.99               0.97               30        59
  Σ ♂ ^B\ B^                                                         Σ 6204                        Σ 6213       Σ 22                  Σ 23            0.35 ±0.03        0.37 ±0.10        0.98 ±0.02         0.97 ±0.03         Σ 159     Σ 219
  Σ ♂ and ♀                                                          Σ 12629                       Σ 12321      Σ 49 ^A^              Σ 53 ^A^        0.39 ±0.08 ^A'^   0.43 ±0.14 ^A'^   0.98 ±0.02 ^A"^    0.98 ±0.02 ^A"^    Σ 203     Σ 244
  *FOHALS -- Food oil of H. annuus L. seeds (500 mg.Kg*^*-1*^*)*                                                                                                                                                                          
  ♀~1~                                                               2014                          2046         10                    11              0.50              0.54              0.98               0.99               39        24
  ♀~2~                                                               2007                          2094         8                     8               0.40              0.38              0.95               0.98               106       34
  ♀~3~                                                               2010                          2035         9                     16              0.45              0.79              0.96               0.99               81        11
  Σ ♀ ^A\ A^                                                         Σ 6031                        Σ 6175       Σ 27                  Σ 35            0.45 ±0.05        0.57 ±0.20        0.96 ±0.02         0.99 ±0.01         Σ 226     Σ 69
  ♂~1~                                                               2037                          2082         10                    10              0.49              0.48              0.95               0.94               116       135
  ♂~2~                                                               2063                          2067         8                     16              0.39              0.77              0.96               0.96               78        89
  ♂~3~                                                               2053                          2078         5                     9               0.24              0.43              0.95               0.97               102       63
  Σ ♂ ^B\ B^                                                         Σ 6153                        Σ 6227       Σ 23                  Σ 35            0.37 ±0.12        0.56 ±0.18        0.95 ±0.01         0.96 ±0.02         Σ 296     Σ 287
  Σ ♂ and ♀                                                          Σ 12184                       Σ 12402      Σ 50 ^A^              Σ 70 ^A^        0.41 ±0.09 ^A'^   0.57 ±0.17 ^A'^   0.96 ±0.01 ^AB"^   0.97 ±0.02 ^AB"^   Σ 522     Σ 356
  *FOHALS -- Food oil of H. annuus L. seeds (1,000 mg.Kg*^*-1*^*)*                                                                                                                                                                        
  ♀~1~                                                               2114                          2083         11                    16              0.52              0.77              0.98               0.98               36        48
  ♀~2~                                                               2148                          2058         11                    13              0.51              0.63              0.96               0.97               84        72
  ♀~3~                                                               2097                          2090         8                     9               0.38              0.43              0.93               0.95               149       106
  Σ ♀ ^A\ A^                                                         Σ 6359                        Σ 6231       Σ 30                  Σ 38            0.47 ±0.08        0.61 ±0.17        0.96 ±0.02         0.97 ±0.01         Σ 269     Σ 226
  ♂~1~                                                               2073                          2026         9                     17              0.43              0.84              0.90               0.96               227       74
  ♂~2~                                                               2065                          2071         12                    13              0.58              0.63              0.99               0.94               20        129
  ♂~3~                                                               2003                          2084         5                     8               0.25              0.38              0.95               0.91               97        207
  Σ ♂ ^B\ B^                                                         Σ 6141                        Σ 6181       Σ 26                  Σ 38            0.42 ±0.17        0.62 ±0.23        0.95 ±0.02         0.94 ±0.03         Σ 344     Σ 410
  Σ ♂ and ♀                                                          Σ 12500                       Σ 12412      Σ 56 ^A^              Σ 76 ^A^        0.45 ±0.12 ^A'^   0.61 ±0.18 ^A'^   0.95 ±0.03 ^AB"^   0.95 ±0.02 ^AB"^   Σ 613     Σ 636
  *FOHALS -- Food oil of H. annuus L. seeds (1,500 mg.Kg*^*-1*^*)*                                                                                                                                                                        
  ♀~1~                                                               2065                          2021         6                     15              0.29              0.74              0.98               0.90               35        236
  ♀~2~                                                               2041                          2081         13                    10              0.64              0.48              0.93               0.89               159       262
  ♀~3~                                                               2068                          2072         11                    14              0.53              0.68              0.89               0.88               247       294
  Σ ♀ ^A\ A^                                                         Σ 6174                        Σ 6174       Σ 30                  Σ 39            0.49 ±0.18        0.63 ±0.14        0.93 ±0.05         0.89 ±0.01         Σ 441     Σ 792
  ♂~1~                                                               2106                          2087         10                    18              0.47              0.86              0.92               0.96               194       94
  ♂~2~                                                               2011                          2088         5                     11              0.25              0.53              0.91               0.94               189       126
  ♂~3~                                                               2039                          2128         14                    16              0.69              0.75              0.98               0.88               38        277
  Σ ♂ ^B\ B^                                                         Σ 6156                        Σ 6303       Σ 29                  Σ 45            0.47 ±0.22        0.71 ±0.17        0.94 ±0.04         0.93 ±0.04         Σ 421     Σ 497
  Σ ♂ and ♀                                                          Σ 12330                       Σ 12477      Σ 59 ^A^              Σ 84 ^A^        0.48 ±0.18 ^A'^   0.67 ±0.15 ^A'^   0.94 ±0.04 ^AB"^   0.91 ±0.03 ^AB"^   Σ 862     Σ 1289
  *FOHALS -- Food oil of H. annuus L. seeds (2,000 mg.kg*^*-1*^*)*                                                                                                                                                                        
  ♀~1~                                                               2084                          2015         11                    13              0.53              0.65              0.89               0.86               245       325
  ♀~2~                                                               2096                          2025         13                    11              0.62              0.54              0.91               0.83               216       407
  ♀~3~                                                               2076                          2002         9                     17              0.43              0.85              0.95               0.94               114       126
  Σ ♀ ^A\ A^                                                         Σ 6256                        Σ 6042       Σ 33                  Σ 41            0.53 ±0.09        0.68 ±0.16        0.92 ±0.03         0.88 ±0.06         Σ 575     Σ 858
  ♂~1~                                                               2057                          2199         16                    20              0.78              0.91              0.94               0.97               143       65
  ♂~2~                                                               2016                          2158         17                    12              0.84              0.56              0.95               0.86               110       347
  ♂~3~                                                               2106                          2133         11                    15              0.52              0.70              0.92               0.89               194       261
  Σ ♂ ^B\ B^                                                         Σ 6179                        Σ 6490       Σ 44                  Σ 47            0.71 ±0.17        0.72 ±0.18        0.93 ±0.02         0.91 ±0.06         Σ 447     Σ 673
  Σ ♂ and ♀                                                          Σ 12435                       Σ 12532      Σ 77 ^A^              Σ 88 ^A^        0.62 ±0.16 ^A'^   0.70 ±0.15 ^A'^   0.92 ±0.02 ^B"^    0.89 ±0.05 ^B"^    Σ 1022    Σ 1531
  *FOHALS (2 g.kg*^*-1*^*) + NEU (50 mg.Kg*^*-1*^*)*                                                                                                                                                                                      
  ♀~1~                                                               2020                          2062         54                    49              2.67              2.38              0.70               0.74               880       738
  ♀~2~                                                               2080                          2052         44                    52              2.12              2.53              0.80               0.68               520       948
  ♀~3~                                                               2008                          2011         50                    54              2.49              2.69              0.69               0.74               892       689
  Σ ♀ ^A\ A^                                                         Σ 6108                        Σ 6125       Σ 148                 Σ 155           2.43 ±0.28        2.53 ±0.15        0.73 ±0.06         0.72 ±0.03         Σ 2292    Σ 2375
  ♂~1~                                                               2031                          2013         50                    67              2.46              3.33              0.73               0.75               769       687
  ♂~2~                                                               2010                          2054         43                    67              2.14              3.26              0.65               0.76               1090      646
  ♂~3~                                                               2042                          2045         56                    71              2.74              3.47              0.64               0.71               1158      855
  Σ ♂ ^B\ B^                                                         Σ 6083                        Σ 6112       Σ 149                 Σ 205           2.45 ±0.30        3.35 ±0.11        0.67 ±0.05         0.74 ±0.03         Σ 3017    Σ 2188
  Σ ♂ and ♀                                                          Σ 12191                       Σ 12237      Σ 297^C^              Σ 360^C^        2.44 ±0.26 ^C'^   2.94 ±0.47 ^C'^   0.70 ±0.06 ^C"^    0.73 ±0.03 ^C"^    Σ 5309    Σ 4563
  *FOHALS (2 g.kg*^*-1*^*) + DXR (5 mg.Kg*^*-1*^*)*                                                                                                                                                                                       
  ♀~1~                                                               2007                          2051         50                    54              2.49              2.63              0.77               0.82               593       449
  ♀~2~                                                               2010                          2033         64                    49              3.18              2.41              0.77               0.88               590       267
  ♀~3~                                                               2094                          2031         51                    54              2.44              2.66              0.84               0.85               406       369
  Σ ♀ ^A\ A^                                                         Σ 6111                        Σ 6115       Σ 165                 Σ 157           2.70 ±0.42        2.57 ±0.14        0.79 ±0.04         0.85 ±0.03         Σ 1589    Σ 1085
  ♂~1~                                                               2128                          2067         67                    66              3.15              3.19              0.85               0.67               372       1033
  ♂~2~                                                               2015                          2053         79                    65              3.92              3.17              0.69               0.71               885       847
  ♂~3~                                                               2054                          2041         66                    60              3.21              2.94              0.64               0.66               1146      1059
  Σ ♂ ^B\ B^                                                         Σ 6197                        Σ 6161       Σ 212                 Σ 191           3.43 ±0.43        3.10 ±0.14        0.73 ±0.11         0.68 ±0.03         Σ 2403    Σ 2939
  Σ ♂ and ♀                                                          Σ 12308                       Σ 12276      Σ 377^C^              Σ 348^C^        3.07 ±0.55 ^C'^   2.83 ±0.32 ^C'^   0.76 ±0.08 ^C"^    0.76 ±0.10 ^C"^    Σ 3992    Σ 4024

Means with the same letter are not significantly different (*p* \< 0.05).

Shown are data from the controls (NaCl, NEU and DXR), an evaluation of the genotoxicity of FOHALS, and an evaluation of the antigenotoxicity of FOHALS (FOHALS + NEU and FOHALS + DXR).

For the first time, this research has provided information on the genotoxic and antigenotoxic effects of THALS. However, genotoxic studies of sunflower oil and oil sunflower ozonized (at a dose limit of 2 g.kg^-1^.d^-1^, based on evidence of toxicity from subchronic studies via intragastric administration of the product) were previously carried out using the MN assay in the bone marrow of mice using male and female Cenp: NMRI mice \[[@B31]\]. In this study, the treatment with sunflower oil did not cause cytotoxic damage to erithrocytes, as reported in the analyses of the PCE/NCE ratio, which corroborate with our findings from the pharmaceutical oil and partially with food oil. Likewise, that research proposes the hypothesis that no clastogenic effect occurs in the bone marrow of animals treated with the sunflower oil under experimental conditions \[[@B31]\].

Other studies have investigated the suitability of different vegetable oils for the human diet, reporting reductions in genotoxicity and cancer potentiation by sesame oil \[[@B32]\] sunflower oil \[[@B33]\], perilla and palm oil \[[@B34]\], olive, sunflower, peanut, corn, and soy oils \[[@B35]\], flax seed oil \[[@B36]\], and coconut oil \[[@B37]\], among others. The possible role of fatty acids, a main component of vegetable oils, in modulating genotoxicity and carcinogenicity has also been studied. The genotoxic activity of vegetable oils \[seed oils of sesame, sunflower, wheat germ, flax, and soy oil, and both first--class extra--virgin and low--grade (refined) olive oil\] consumed by humans were also tested in a *Drosophila* somatic mutation and recombination test (the *Drosophila melanogaster* SMART assay) \[[@B30]\]. Flax oil produced the strongest response, while sesame, wheat germ, and soy oil showed some genotoxic activity. Sunflower oil and the low--grade olive oil gave inconclusive results or negative biological diagnoses, possibly due to lower concentrations of PUFAs, even as refined products, and extra--virgin olive oil was clearly not genotoxic. It has been argued that the genotoxicity of an oil is most likely due to the fatty acid composition of the oil, which after peroxidation can form specific DNA--adducts. Such results were in general agreement with evidence from experimental and epidemiological studies summarized by Bartsch and collaborators (1999) \[[@B38]\]: n--PUFAs are related to the generation of oxidative DNA damage, a high intake of n--6 PUFAs is implicated in some types of cancers, and n--9 MUFAs and n--3 PUFAs may have a role in cancer prevention. Additionally, it was suggested that the relative concentrations of short--chain C18:3 n--3 linolenic acid, C18:2 n--6 linoleic acid, and polyphenols are the major factors responsible for the genotoxicity of cooking oils in the SMART assay \[[@B30]\]. Despite the existence of this information, contradictory or inconclusive data were found in the literature. For instance, one study reported that linoleic acid (C18:2 n--6 PUFA) suppressed cancer cell proliferation \[[@B39]\], while other studies indicated an enhancing effect on carcinogenesis \[[@B40],[@B41]\]. Oleic acid (C18:1, n--9 MUFA), a promoter of cancer cell proliferation \[[@B39]\], has also been reported to be an effective anticancer and antigenotoxic agent \[[@B42],[@B43]\]. Linolenic acid (C18:3 short--chain n--3 PUFA) had anticancer activity in some studies \[[@B39],[@B44]\], but promoted cancer in other studies \[[@B41],[@B45]\]. Phenolic compounds, another important constituent of vegetable oils, are present in the unsaponifiable lipid phase. Phenolics are involved in both extra- and intracellular processes, inducing cytosolic detoxifying mechanisms, microsomal enzyme activation, and the scavenging of free radicals \[[@B46],[@B47]\]. Evidence indicates that polyphenols can inhibit the genotoxicity of genotoxic agents \[[@B48],[@B49]\] and function as anticancer agents \[[@B50]\].

The clastogenic and cytotoxic effects from heated sunflower oil were studied in lymphocytes, hepatocytes (HepG2) and in human umbilical vein endothelial cells (HUVEC) \[[@B19]\]. In lymphocytes incubated with water extract of heated sunflower oil containing 0.075 or 0.15 μM of thiobarbituric acid--reactive substances (this extract has a high content in polar aldehydes), the rate of chromosomal breakage was 18.4% and 23.1%, compared to 8.7% and 6.6%, or 8.1% and 9.2%, respectively in lymphocytes incubated with the same volume of a water extract from non--heated oil or distilled water. In HepG2 or HUVEC cells, the cytotoxic properties of heated sunflower oil were dose dependent, and the cytotoxicity occurred at concentrations as low as 0.25 μM. In contrast, the same volume of non--heated oil or distilled water was non--toxic for these cells. The results show that a water extract obtained from heated oil is clastogenic and, in higher doses, cytotoxic. These data also suggested that a water extract, obtained from culinary oils submitted to heat stress, with a high content of aldehydes is clastogenic. It was speculated that the ingestion of large amounts of these products may also impact human health, especially in those diseases secondary to chromosomal breakage such as certain congenital malformations and certain types of cancer. This last fact can be corroborated by previous reports indicating that the administration of thermally stressed sunflower oil to rats is teratogenic \[[@B51]\].

Doxorubicin (DXR) is an important anthracyclines anticancer agent. It is a valuable component of various chemotherapeutic regimens for breast carcinoma and small-cell lung carcinoma. In metastatic thyroid carcinoma, DXR is most likely the best available agent \[[@B20]\]. However, DXR has been reported to induce micronuclei, chromatid and chromosome aberrations, and DNA single- and double-strand breaks *in vitro* and *in vivo*\[[@B52]-[@B56]\]. The genotoxicity of anticancer drugs is of special interest because of the risk of inducing secondary malignancies. Therefore, it is essential to screen for newer pharmacological agents that can protect the normal cells against DXR--induced cumulative (geno) toxicity. Many plants that have been widely used in traditional medicine are less toxic than pharmaceutical agents and have recently attracted the attention of researchers around the world. Plants contain many compounds, and it is likely that these can provide better protective effects than a single molecule \[[@B57]\]. The presence of many molecules in plants may be advantageous, as some of them may counteract the toxicity of others, and as a result, the net effect may be beneficial for therapeutic purposes. For example, the effect of various concentrations (200, 250, 300, 350, and 400 mg/kg body weight) of *Aegle marmelos* on the doxorubicin (DXR)--induced genotoxic effects in mice bone marrow was studied \[[@B20]\]. Treatment of mice with different concentrations of DXR (5, 10, or 15 mg.kg^-1^ body weight) resulted in a dose--dependent elevation in the frequency of micronucleated polychromatic and normochromatic erythrocytes in mouse bone marrow, and it was accompanied by a DXR dose--dependent decline in the PCE/NCE ratio. The treatment of mice with *Aegle marmelos*, orally once daily for 5 consecutive days before DXR treatment, significantly reduced the frequency of DXR--induced micronuclei and significant increased the PCE/NCE ratio at all scoring times. This observed chemoprotective effect may be due to the sum total of interaction between different ingredients of this complex mixture. The degree of protection may depend on the interaction of components individually or collectively with the genotoxic agent. The plausible mechanisms of action of *Aegle marmelos* in protecting against DXR--induced genomic insult were scavenging of O~2~^•--^ and ^•^OH and other free radicals, increase in antioxidant status, restoration of topoisomerase II activity, and inhibition of the formation of DXR--iron complex \[[@B20]\]. Another study was undertaken to evaluate the genotoxic potential of *Copaifera langsdorffii* Desf. leaf hydroalcoholic extract and its influence on the genotoxicity induced by chemotherapeutic agent DXR using the *Swiss* mouse peripheral blood micronucleus test. The results of this study demonstrated that *C. langsdorffii* Desf. was not itself genotoxic and that in animals treated with *C. langsdorffii* Desf. and DXR, the number of micronuclei was significantly decreased compared to animals receiving DXR alone. The putative antioxidant activity of one or more of the active compounds of *C. langsdorffii* Desf., including two major flavonoid heterosides (quercitrin and afzelin), may explain the effect of this plant on DXR genotoxicity \[[@B18]\].

Conclusions
===========

In conclusion, this research observed an absence of genotoxicity of a tincture and two oils of sunflower seeds, regardless of the dose tested and the treatment time (24--48 h), but sex-independent (sunflower tincture) or sex-dependent (sunflower oils). Antigenotoxic effects (anticlastogeny and/or antianeugeny) were observed using only a dose of the sunflower tincture in association with the chemotherapy agent DXR. Therefore, the sunflower tincture can promote a partial protection against the genotoxic effects induced by DXR. The sunflower tincture no showed systemic toxicity and it was dose- and time-independent and sex-dependent, whereas the systemic toxicity of sunflower oil can be dependent on its source and its highest dose used.

Other studies involving the genotoxicity and antigenotoxicity of *H. annuus* L. extracts and oils (seeds, flowers and leaves) should be conducted \[including genotoxicity assays with *Salmonella typhimurium* test (Ames test) as an indicator of potential carcinogenicity to mammals, gene mutation test in mammalian cells (mouse lymphoma assay), cytogenetic and aneuploidy tests *in vitro*, micronucleus test in cultured cells *in vitro*, fluorescent *in situ* hybridization (FISH) test for mutagenesis, comet test to detect of DNA damage and repair in individual cells, and functional genomic and proteomic tests for mutagenesis (cDNA microarrays and other array analyses)\], to characterize the potential effects and genotoxic and antigenotoxic mechanisms and, importantly, for the establishment of limits for human consumption, the delineation of potential risks to human health, and for rational strategies for implementing chemo-preventive measures.
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